Alfa S.A.B. de C.V. (ALFFF) Q2 2025 Earnings Call Transcript

Alfa (ALFFF) reported Q2 2025 results, underscoring its successful transformation into a pure-play packaged food company (SIGMA), which has enhanced its valuation and GICS classification. SIGMA delivered consistent performance with positive sequential momentum in sales and EBITDA, achieving its second highest accumulated comparable EBITDA of $468 million despite significant protein input cost pressures, notably turkey. Regionally, Mexico saw strong sales growth and the US posted record EBITDA, while Europe benefited from a substantial EUR 68 million insurance gain for flood damages, earmarked for capacity expansion. The company maintains a strong financial position (2.6x net debt/EBITDA) and expects to sustain positive sequential trends into H2 2025, prioritizing cost management and reinforcing its consumer-focused identity.

Analysis

Alfa S.A.B. de C.V. has executed a pivotal strategic transformation into a pure-play food company, Alfa|SIGMA, which has successfully narrowed its valuation gap against peers and prompted a reclassification to consumer staples. Despite a challenging macro environment with low consumer confidence, the company delivered its second-highest accumulated comparable EBITDA of $468 million, demonstrating operational resilience while maintaining a strong balance sheet with a 2.6x net debt-to-EBITDA ratio. However, performance is divergent across regions. Mexico posted a robust 12% currency-neutral sales growth through aggressive pricing actions, but this led to a 5% decline in peso-denominated EBITDA due to softer Foodservice demand and negative product mix shifts. In contrast, the U.S. division achieved a record Q2 EBITDA of $56 million, highlighting strength in its national and Hispanic brands. European results were significantly impacted by a non-recurring insurance gain of €68 million related to a prior flood, which will fund a €134 million new plant and a €23 million capacity expansion aimed at long-term margin recovery. The primary headwind remains severe raw material inflation, particularly turkey prices which are up over 50% year-over-year, forcing the company to implement targeted revenue management and sourcing diversification to protect margins.

Key Decisions for Investors

• Investors should closely monitor key input costs, particularly turkey prices and the MXN/USD exchange rate, as these variables are the primary determinants for margin recovery in the second half of 2025.
• It is crucial to assess the effectiveness of management's revenue and cost initiatives in Mexico, as the ability to balance aggressive pricing with volume and mix will dictate the segment's profitability.
• When evaluating the European segment, investors should normalize for the one-time €68 million insurance gain and focus on underlying volume recovery and the execution timeline for the new Spanish plants, which are critical to achieving the 2027 margin target of 7-8%.
• Consider the ongoing corporate re-rating narrative, as the completed simplification and upcoming rebranding could continue to act as a positive catalyst for the stock's valuation, independent of near-term operational results.